Report of two cases of idiopathic membranousnephropathy with high antibody titer treated with plasma replacement combined with CD20 monoclonal antibody
<正>特发性膜性肾病（idiopathic membranous nephropathy,IMN）是原发性肾病综合征的主要病因,患病人数在我国呈逐年上升趋势[1]。根据2012年改善全球肾脏病预后组织（Kidney Disease:Improving Global Outcomes,KDIGO）[2]治疗指南,建议表现为肾病综合征的IMN患者有以下情况之一的考虑应用免疫抑制剂治疗:（1）经过至少6个月的降血压和降蛋白尿治疗,...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2020-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57906645&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|